Highlights of the important and interesting in the world of healthcare:
It’s election day. Research!America offers to help you better understand your candidates’ positions on issues in health and research (Opens in a new window).
No magic bullet for diabetes. Amgen Inc. (NASDAQ:AMGN (Opens in a new window)) Chief Executive Kevin Sharer said Monday at the Cleveland Clinic’s medical innovation summit on obesity and diabetes that he doesn’t envision the drug industry developing new medicines over the next decade that stem the rising tide of diabetes, according to Dow Jones (Opens in a new window).
(Opens in a new window)
Navina’s AI Copilot Eases the Value-Based Burden, Study Shows (Opens in a new window)
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
Should genes be patentable? The U.S. Department of Justice’s reversal of longstanding policy with its recent statement that human and other genes should be ineligible for patents because they are part of nature could have huge impacts on medicine and the biotechnology industry, according to the New York Times (Opens in a new window).
Got germs? GoJo Industries Inc. in Akron, Ohio, has reacquired the Purell hand sanitizer brand from Johnson & Johnson’s consumer products division, Crain’s Cleveland Business reports (Opens in a new window). Just in time for cold and flu season.
Pounding on Medicare’s door. Sen. Charles Grassley (R-Iowa) shot off another letter to CMS Administrator Dr. Donald Berwick, focusing on possible conflicts of interest among Medicare contractors that conduct fraud investigations, according to FierceHealthcare (Opens in a new window).
(Opens in a new window)
The Top 5 Home Care Franchise Opportunities in the U.S. (Opens in a new window)
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Credit thumbs up for HCA. Credit rating agency Fitch raised its sights on the debt of HCA Inc. because the for-profit hospital chain could significantly pay down debt with $2.5 billion in proceeds it expects from its third initial public offering, according to Bloomberg Businessweek (Opens in a new window).